指南与共识消化系统肿瘤

结直肠癌前病变与共识分子亚型1和2相关

Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2.
指南 / 共识 · Ann Oncol · 2018-01-01

研究整合散发性(N=311)和遗传性(N=78)患者人群的腺瘤性和锯齿状息肉转录组数据集,用CMS随机森林分类器分析癌变通路。结果显示癌前病变以CMS2和CMS1亚型为主:腺瘤性息肉呈CMS2样表型伴WNT和MYC激活,增生性和锯齿状息肉呈CMS1样表型伴显著免疫激活。CMS1样息肉与锯齿状病理、右侧解剖位置和BRAF突变强相关。

要点

  • 癌前息肉转录组分型以CMS2和CMS1亚型为主。
  • 腺瘤性息肉呈CMS2样表型,伴WNT和MYC激活。
  • CMS1样息肉与锯齿状病理、右侧位置和BRAF突变强相关。

核心结论

  • 作者基于癌前病变观察提出结直肠癌变中CMS分类相关的通路激活模型。
  • 腺瘤性息肉大多为CMS2,多数增生性和锯齿状息肉为CMS1,并可能在演变为癌过程中转变为其他CMS组。
  • 研究结果揭示癌前结肠息肉的转录景观,可能有助于指导未来CRC生物标志物或预防治疗的开发。

研究设计与样本

  • 整合不同公开和专有队列的散发性(N=311)和遗传性(N=78)患者人群腺瘤性和锯齿状息肉转录组数据集。
  • 使用CMS随机森林(RF)分类器对癌变通路进行综合分析。

主要发现

  • 散发性和遗传性息肉的转录组分型显示CMS2和CMS1亚组为癌前病变的主要分子亚型。
  • 来自散发性或遗传性病例(包括Lynch综合征)的腺瘤性息肉显示CMS2样表型,伴WNT和MYC激活。
  • 具有CMS1样表型的增生性和锯齿状息肉具有显著的免疫激活。
  • 罕见的CMS4样表型腺瘤显示基质特征显著富集,并伴转化生长因子-β激活。
  • CMS1样息肉与锯齿状病理、右侧解剖位置和BRAF突变强相关。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

BACKGROUND: Gene expression-based profiling of colorectal cancer (CRC) can be used to identify four molecularly homogeneous consensus molecular subtype (CMS) groups with unique biologic features. However, its applicability to colorectal premalignant lesions remains unknown. PATIENTS AND METHODS: We assembled the largest transcriptomic premalignancy dataset by integrating different public and proprietary cohorts of adenomatous and serrated polyps from sporadic (N = 311) and hereditary (N = 78) patient populations and carried out a comprehensive analysis of carcinogenesis pathways using the CMS random forest (RF) classifier. RESULTS: Overall, transcriptomic subtyping of sporadic and hereditary polyps revealed CMS2 and CMS1 subgroups as the predominant molecular subtypes in premalignancy. Pathway enrichment analysis showed that adenomatous polyps from sporadic or hereditary cases (including Lynch syndrome) displayed a CMS2-like phenotype with WNT and MYC activation, whereas hyperplastic and serrated polyps with CMS1-like phenotype harbored prominent immune activation. Rare adenomas with CMS4-like phenotype showed significant enrichment for stromal signatures along with transforming growth factor-β activation. There was a strong association of CMS1-like polyps with serrated pathology, right-sided anatomic location and BRAF mutations. CONCLUSIONS: Based on our observations made in premalignancy, we propose a model of pathway activation associated with CMS classification in colorectal carcinogenesis. Specifically, while adenomatous polyps are largely CMS2, most hyperplastic and serrated polyps are CMS1 and may transition into other CMS groups during evolution into carcinomas. Our findings shed light on the transcriptional landscape of premalignant colonic polyps and may help guide the development of future biomarkers or preventive treatments for CRC.

来源:Ann Oncol,查看原文。版权归原作者所有。

引用

  1. Chang K, Willis JA, Reumers J, et al. Colorectal premalignancy is associated with consensus molecular subtypes 1 and 2. Ann Oncol. 2018. PMID: 30412224. doi:10.1093/annonc/mdy337

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。